FEMY vs LEN · rev $1.6M vs rev $34.19B
Femasys Inc (FEMY) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Femasys Inc (FEMY) is a medical instruments & supplies company listed on US.
LEN (LEN) common stock.
Latest reported FEMY revenue for 2024-12-31 was $1.6M. Net income was -$18.8M. Revenue was up 52.0% from 2023-12-31 to 2024-12-31. FEMY currently screens at market cap $925.2K.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
FEMY currently screens at market cap $925.2K. LEN currently screens at market cap $0.
Not investment advice. Open the FEMY and LEN stock pages for the full models.
Not investment advice.